Signet Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
2,727
+232
+9% +$237K 2.61% 5
2026
Q1
$2.3M Buy
2,495
+247
+11% +$250K 2.19% 9
2025
Q4
$2.42M Buy
+2,248
New +$2.15M 2.31% 7

Other funds holding LLY

Signet Private Wealth's LLY Position: Q2 2026 in Review

Signet Private Wealth increased its Eli Lilly (LLY) stake by 9.3% in Q2 2026, buying an estimated $237K and bringing the position to 2,727 shares worth $3.27M. The position accounts for 2.61% of the portfolio, ranked #5.

Signet Private Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signet Private Wealth held 2,727 shares of Eli Lilly worth $3.27M as of Q2 2026.
  • Signet Private Wealth bought 232 Eli Lilly shares in Q2 2026, an estimated $237K.
  • Eli Lilly made up 2.61% of Signet Private Wealth's portfolio in Q2 2026, its #5 holding.
  • Signet Private Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signet Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.